Both plant-derived and synthesized cannabinoids, such as tetrahydrocannabinol (THC) and cannabidiol (CBD), are increasingly being prescribed or suggested for medicinal purposes, including the management of mental health disorders and their associated symptoms. However, the utilization of these compounds to address various mental health conditions is advancing more swiftly than the scientific substantiation of their effectiveness. Within this study, the authors conducted an evaluation of the existing scientific literature concerning the impacts of both natural and synthetic THC and CBD formulations in relation to a spectrum of mental disorders, encompassing depression, anxiety, attention deficit hyperactivity disorder (ADHD), Tourette syndrome, post-traumatic stress disorder (PTSD), and psychosis. The aim was to ascertain whether there is comprehensive evidence to validate their application for these conditions.
About the Author
Our deep love of plants and fascination with Cannabis has enabled over 25 years of successful small-scale Marijuana cultivation from indoor hydroponics, greenhouses, and outdoor growing set-ups.
As Cannabis laws around the world change, *we support the movement toward freedom of choice for responsible, consenting adults who wish to experience the joy and wonder of growing a Cannabis plant.